Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + paclitaxel in HER2-negative metastatic breast cancer
2012-003743-30Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2012
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of bevacizumab and paclitaxel in breast cancer, sponsored by Karolinska University Hospital. Primary endpoint: Frequency and grade of bleeding complications after metastatic lesion biopsies. Started Sep 2012; status: active.
02
Drugs
bevacizumabpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-003743-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003743-30.